Willow Biosciences (TSX:WLLW) Deferred Tax : C$0.00 Mil (TTM As of Mar. 2025)

View and export this data going back to 1983. Start your Free Trial

What is Willow Biosciences Deferred Tax?

Change In Deferred Tax represents future tax liability or asset, resulting from temporary differences between book (accounting) value of assets and liabilities, and their tax value. This arises due to differences between financial accounting for shareholders and tax accounting.

Willow Biosciences's change in deferred tax for the three months ended in Mar. 2025 was C$0.00 Mil. Its change in deferred tax for the trailing twelve months (TTM) ended in Mar. 2025 was C$0.00 Mil.

Willow Biosciences Deferred Tax Historical Data

The historical data trend for Willow Biosciences's Deferred Tax can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Willow Biosciences Deferred Tax Chart

Willow Biosciences Annual Data

Trend

Jun15

Jun16

Jun17

Jun18

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

Deferred Tax

Get a 7-Day Free Trial

-0.02

Willow Biosciences Quarterly Data
	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24	Mar25
Deferred Tax	Get a 7-Day Free Trial															-	-	-	-	-

Willow Biosciences Deferred Tax Calculation

Deferred Tax for the trailing twelve months (TTM) ended in Mar. 2025 adds up the quarterly data reported by the company within the most recent 12 months, which was C$0.00 Mil.

Willow Biosciences Deferred Tax Related Terms

Thank you for viewing the detailed overview of Willow Biosciences's Deferred Tax provided by GuruFocus.com. Please click on the following links to see related term pages.

Willow Biosciences Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Willow Biosciences Inc (TSX:WLLW) » Definitions » Deferred Tax

Comparable Companies

Traded in Other Exchanges

CANSF:USA 45CN:Germany

Address

202, 1201 5th Street SW, Calgary, AB, CAN, T2R 0Y6

Website

https://www.willowbio.com

Willow Biosciences Inc is a Canadian biotechnology company. It has only one reportable segment engaged in developing and producing high-purity, plant-derived ingredients for consumer care, food and beverage, and pharmaceutical products. It has a geographic presence in Canada and the United states, in which it generates the majority of its revenue from the United states.

Executives

Christopher Kenneth Savile	Director, Senior Officer
Travis Doupe	Senior Officer
Patricia Ranija Choudhary	Director
Sadiq Lalani	Director
Barbara Elaine Munroe	Director
Peter Seufer-wasserthal	Director
Trevor Anthony Peters	Director, Senior Officer
Troy Tapan Talkkari	Senior Officer

Willow Biosciences Headlines

No Headlines